Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Pfizer
Stanford University
Therapeutic Advances in Childhood Leukemia Consortium
Karyopharm Therapeutics Inc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Rhizen Pharmaceuticals SA
Kyowa Kirin Co., Ltd.